BDKRB2 and neoplasm: This differential activity suggests that 14‐MAP might preferentially target mature vessels, such as small arteries within the tumor microenvironment [46]. Furthermore, 14‐MAP demonstrated significant interference in the BK/B2R pathway over the Des‐Arg9‐BK/B1R pathway in endothelial cells (Fig. 3).